QUSVM
Qiming U.S. Ventures Management Portfolio holdings
AUM
$23.6M
This Quarter Return
+27.52%
1 Year Return
-18.39%
3 Year Return
+715.34%
5 Year Return
–
10 Year Return
–
AUM
$95.2M
AUM Growth
+$95.2M
(+15%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
ICVX
1
DELISTED
Icosavax, Inc. Common Stock
ICVX
| $34.9M | 36.63% | 3,510,228 | – | – |
|
2
Ventyx Biosciences
VTYX
$171M
| $24.5M | 25.72% | 746,370 | – | – |
|
3
Jasper Therapeutics
JSPR
$45.5M
| $11.7M | 12.26% | 8,519,648 | – | – |
|
4
HilleVax
HLVX
$105M
| $9.61M | 10.1% | 558,923 | – | – |
|
5
Tourmaline Bio
TRML
$601M
| $8.92M | 9.37% | 2,932,606 | – | – |
|
|
ELEV
6
DELISTED
Elevation Oncology
ELEV
| $3.6M | 3.79% | 2,370,142 | – | – |
|
7
Kezar Life Sciences
KZR
$28.9M
| $2.03M | 2.13% | 828,711 | – | – |
|